Purchase Order 75N93024P00815
Award Date 7/3/24
Potential Completion Date 9/20/24
Potential Value $107K
Federal Agency
Awardee
Ultimate Awardee
Not listed NAICS Category
PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Not Competed under SAP
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Potomac, MD 20850, USA
Solicitation Procedures
Simplified Acquisition
Number Of Offers Received
1
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- This is a firm fixed price purchase order contract awarded by the Department of Health and Human Services' National Institutes of Health (NIH) National Institute of Allergy and Infectious Diseases to Maxcyte, Inc., a commercial cell engineering company. The $24,200.00 contract is for the provision of MAXCYTE PROCESSING ASSEMBLIES. Maxcyte has previously held prime federal contracts with agencies like NIH, the Food and Drug Administration, and Department of Veterans Affairs to deliver specialized...
- This is a federal contract award by the Department of Health and Human Services' National Institutes of Health, National Institute of Allergy and Infectious Diseases to Maxcyte, Inc. for a Transfection System. The contract has a firm fixed price of $81,385.00 and was awarded on August 8, 2018 with a completion date of September 7, 2018. The award was made without a set-aside. Maxcyte, Inc. is a commercial cell engineering company that has previously provided specialized laboratory equipment...
- The U.S. Department of Health and Human Services (HHS), National Institute of Allergy and Infectious Diseases (NIAID), awarded a one-year, firm-fixed-price purchase order to Maxcyte, Inc. for the lease of one MaxCyte® GT Flow Transfection System, valued at $100,000.00. The equipment will be used to support biomedical research at the agency's facilities in Bethesda, Maryland. This award is not associated with a larger contract vehicle and does not utilize a set-aside designation. Maxcyte, Inc. is...
- This firm fixed-price purchase order was awarded by the Food and Drug Administration (FDA) to Maxcyte, Inc., a small business prime contractor, on June 16, 2020 for a "Scalable Transfection System." The contract has a ceiling value of $82,100 and a completion date of September 30, 2020. Maxcyte has previously provided specialized laboratory equipment and technologies, such as cell processing systems, electroporation, and scalable transfection systems, to federal agencies including...
- The Department of Health and Human Services' National Institutes of Health's National Institute of Allergy and Infectious Diseases awarded a $49,710 purchase order to Maxcyte, Inc. of Potomac, Maryland under a firm fixed price contract. The contract is for the delivery of a Maxcyte E-ATX Cell Processor to support the NIH/NIAID's research efforts through September 15, 2023. As the prime contractor, Maxcyte will provide its cell processing equipment without support from major subcontractors. The...
- This federal contract was awarded by the Department of Health and Human Services' National Institutes of Health National Institute of Allergy and Infectious Diseases to Maxcyte, Inc., a leading commercial cell engineering company, for the delivery of a PROCESSING ASSEMBLY, CL-1.1 3.5-ML (REAGENTS). The firm fixed price contract, with a potential value of $12,130.00, has an award date of February 15, 2019 and a completion date of April 19, 2019. There was no set-aside used for this contract...
- The Department of Health and Human Services' National Institutes of Health National Institute of Diabetes and Digestive and Kidney Diseases awarded a $59,500 purchase order to Maxcyte, Inc. to acquire a MaxCyte ATX Scalable Transfection System, along with processing assemblies and software licenses. The non-competitive award was justified as Maxcyte's proprietary electroporation technology is necessary to allow for the manipulation of transcription factor protein expression. The purchase...
- The National Heart Lung and Blood Institute, a civilian agency within the Department of Health and Human Services, awarded a $55,200.00 firm fixed price purchase order to Maxcyte, Inc., a for-profit corporate entity based in Rockville, Maryland. The contract is for the procurement of an EXPERT ATX Electroporation Platform, Generation 3 with accessories, to be used for developing gene editing tools for in vivo gene therapy research. This specialized laboratory equipment supports the agency's...
- The Department of Veterans Affairs Veterans Health Administration awarded a $165,000.00 firm fixed price purchase order to Maxcyte, Inc., a leading commercial cell engineering company, for the provision of specialized laboratory equipment and technologies. This contract, which did not utilize a set-aside designation, is for the delivery of transfection systems to support the agency's biomedical research and clinical care missions. Through past prime federal contract awards, Maxcyte has...
- This is a firm fixed-price purchase order awarded by the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health (NIH), to Life Technologies Corporation, a division of Thermo Fisher Scientific, for the procurement of Expifectamine Transfection Kit and EXPI293 Expression Medium. The contract has a ceiling value of $95,780.00 and a period of performance from October 1, 2018 to September 30, 2019. This order was competed on the open market and did...